Market cap
₹518 Cr
Revenue (TTM)
₹41 Cr
P/E Ratio
50.9
P/B Ratio
9.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 24.06 | 22.84 | -- |
| EBIT | -- | -- | 44.51 | 29.33 | -- |
| Net Profit | -- | -- | 67.21 | 35.68 | -- |
| EPS | -- | -- | 22.95 | 22.46 | -- |
| Book Value | -- | -- | 38.64 | 31.88 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 24.32 | -- | 26.34 | 22.61 | 24.00 |
| Net Margin
| 20.95 | -- | 24.00 | 18.02 | 20.82 |
| Return on equity
| 24.77 | -- | 24.35 | 23.49 | 26.47 |
| Return on Capital
| 33.51 | -- | 32.53 | 32.12 | 35.86 |
| Return on Assets
| 20.20 | -- | 20.33 | 19.71 | 20.55 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.00 |
Profitability
ROCE
32.53
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
32.53
|
32.12
|
35.86
|
34.80
|
30.19
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
24.35
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
24.35
|
23.49
|
26.47
|
26.33
|
24.41
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
20.33
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
20.33
|
19.71
|
20.55
|
17.59
|
14.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
26.34
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
26.34
|
22.61
|
24.00
|
22.57
|
16.55
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
24.00
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
24.00
|
18.02
|
20.82
|
17.95
|
13.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Profit Margin
26.36
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
26.36
|
20.09
|
24.37
|
21.59
|
16.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
24.06
--
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
24.06
|
35.67
|
10.14
|
-5.61
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
44.51
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
44.51
|
27.85
|
17.09
|
28.76
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
67.21
--
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
67.21
|
13.93
|
31.12
|
24.23
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
22.95
--
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
22.95
|
13.93
|
31.12
|
24.23
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Book Value Growth
88.55
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
88.55
|
26.78
|
30.51
|
30.33
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
--
|
--
|
--
|
--
|
0.12
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
--
|
--
|
--
|
--
|
0.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
13.30
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
13.30
|
5.26
|
3.62
|
2.43
|
1.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
11.01
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
11.01
|
4.00
|
2.87
|
2.13
|
1.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
119.77
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
119.77
|
138.11
|
60.43
|
31.30
|
43.81
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
11.75
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
11.75
|
20.13
|
22.03
|
23.34
|
11.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.82
--
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
0.82
|
1.06
|
0.93
|
0.95
|
1.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
51.05
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
51.05
|
66.37
|
78.87
|
64.43
|
41.23
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
61.55
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
61.55
|
53.88
|
43.93
|
35.99
|
38.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
47.49
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
47.49
|
70.00
|
130.39
|
181.36
|
160.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
65.11
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
65.11
|
50.25
|
-7.59
|
-80.95
|
-81.34
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
22.44
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
22.44
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
4.18
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
4.18
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
15.12
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
15.12
|
-0.06
|
-1.16
|
-1.20
|
-1.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
228
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Cryogenic OGS
|
228
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|